Table 2.
HDL concentrations categorised by HIV immune and virological status, markers renal function, infective markers and hospital stay and mortality outcome.
| HDL (median [IQR]) (mmol/L) | p - value | |
|---|---|---|
| CD4 (cells/mm3) | ||
| < 50 | 0.58 (0.39 - 0.71) | p = 0.042 |
| 50 – 350 | 0.62 (0.48 - 0.86) | |
| > 350 | 0.83 (0.51 - 1.22) | |
| HIV Viral Load < 1000 (copies/ml) | ||
| < 1000 | 0.75 (0.55 - 1.09) | p = 0.001 |
| > 1000 | 0.54 (0.4 - 0.72) | |
| Creatinine (umol/L) | ||
| < 200 | 0.61 (0.43 - 0.88) | p = 0.560 |
| > 200 | 0.65 (0.45 - 0.87) | |
| CKD - EPI (mL/min/1.73m2) | ||
| < 30 | 0.63 (0.44 - 0.86) | p = 0.934 |
| > 30 | 0.61 (0.44 - 0.88) | |
| AKI Severity | ||
| Mild | 0.64 (0.49 - 0.99) | p = 0.593 |
| Moderate | 0.58 (0.42 - 0.79) | |
| Severe | 0.64 (0.44 - 0.84) | |
| CRP (mg/L) | ||
| 5 to 30 | 0.86 (0.52 - 1.16) | p = 0.036 |
| Above 30 | 0.58 (0.44 - 0.76) | |
| WCC (x109/L) | ||
| 0 – 11 | 0.66 (0.50 -0.93) | p = 0.018 |
| > 11 | 0.53 (0.35 - 0.74) | |
| Albumin (g/L) | ||
| < 20 | 0.55 (0.41 - 0.72) | p < 0.001 |
| > 20 | 0.77 (0.52 - 1.07) | |
| Duration of stay | ||
| Survivors | ||
| < 10 days | 0.53 (0.4 - 0.86) | p = 0.034 |
| > 10 days | 0.66 (0.48 - 0.96) | |
| Deceased | ||
| < 10 days | 0.60 (0.5 - 0.73) | p = 0.205 |
| > 10 days | 0.71 (0.66 - 1.07) | |
| Outcome | ||
| Discharge | ||
| Recovered | 0.58 (0.42 - 0.86) | p = 0.097 |
| Deceased | 0.7 (0.58 - 0.99) | |
| 3 month follow up | ||
| Recovered | 0.65 (0.5 - 0.76) | p = 0.953 |
| Deceased | 0.66 (0.45 - 0.89) |